Libby Ellis, Alison J. Canchola, and Scarlett Lin Gomez, Cancer Prevention Institute of California, Fremont; Libby Ellis, David Spiegel, and Uri Ladabaum, Stanford Cancer Institute; David Spiegel, Uri Ladabaum, and Robert Haile, Stanford University School of Medicine, Stanford; Robert Haile, Cedars-Sinai Medical Center, Los Angeles; and Scarlett Lin Gomez, University of California, San Francisco, San Francisco, CA.
J Clin Oncol. 2018 Jan 1;36(1):25-33. doi: 10.1200/JCO.2017.74.2049. Epub 2017 Oct 16.
Purpose Racial/ethnic disparities in cancer survival in the United States are well documented, but the underlying causes are not well understood. We quantified the contribution of tumor, treatment, hospital, sociodemographic, and neighborhood factors to racial/ethnic survival disparities in California. Materials and Methods California Cancer Registry data were used to estimate population-based cancer-specific survival for patients diagnosed with breast, prostate, colorectal, or lung cancer between 2000 and 2013 for each racial/ethnic group (non-Hispanic black, Hispanic, Asian American and Pacific Islander, and separately each for Chinese, Japanese, and Filipino) compared with non-Hispanic whites. The percentage contribution of factors to overall racial/ethnic survival disparities was estimated from a sequence of multivariable Cox proportional hazards models. Results In baseline models, black patients had the lowest survival for all cancer sites, and Asian American and Pacific Islander patients had the highest, compared with whites. Mediation analyses suggested that stage at diagnosis had the greatest influence on overall racial/ethnic survival disparities accounting for 24% of disparities in breast cancer, 24% in prostate cancer, and 16% to 30% in colorectal cancer. Neighborhood socioeconomic status was an important factor in all cancers, but only for black and Hispanic patients. The influence of marital status on racial/ethnic disparities was stronger in men than in women. Adjustment for all covariables explained approximately half of the overall survival disparities in breast, prostate, and colorectal cancer, but it explained only 15% to 40% of disparities in lung cancer. Conclusion Overall reductions in racial/ethnic survival disparities were driven largely by reductions for black compared with white patients. Stage at diagnosis had the largest effect on racial/ethnic survival disparities, but earlier detection would not entirely eliminate them. The influences of neighborhood socioeconomic status and marital status suggest that social determinants, support mechanisms, and access to health care are important contributing factors.
美国癌症生存的种族/民族差异有大量记录,但根本原因尚不清楚。我们量化了肿瘤、治疗、医院、社会人口统计学和社区因素对加利福尼亚州种族/民族生存差异的贡献。
使用加利福尼亚癌症登记处的数据,根据每个种族/民族群体(非西班牙裔黑人、西班牙裔、亚裔美国人和太平洋岛民,以及分别为华裔、日裔和菲律宾裔),估计了 2000 年至 2013 年间诊断为乳腺癌、前列腺癌、结直肠癌或肺癌的患者的基于人群的癌症特异性生存情况,并与非西班牙裔白人进行了比较。通过一系列多变量 Cox 比例风险模型来估计这些因素对总体种族/民族生存差异的贡献百分比。
在基线模型中,与白人相比,所有癌症部位的黑人患者的生存率最低,而亚裔美国人和太平洋岛民患者的生存率最高。中介分析表明,诊断时的分期对总体种族/民族生存差异的影响最大,占乳腺癌差异的 24%、前列腺癌差异的 24%,以及结直肠癌差异的 16%至 30%。在所有癌症中,社区社会经济地位都是一个重要因素,但仅对黑人和西班牙裔患者如此。婚姻状况对种族/民族差异的影响在男性中比女性更强。对所有协变量进行调整后,解释了乳腺癌、前列腺癌和结直肠癌总体生存差异的约一半,但仅解释了肺癌差异的 15%至 40%。
总体而言,种族/民族生存差异的缩小主要是由于与白人相比黑人患者的差异缩小所致。诊断时的分期对种族/民族生存差异的影响最大,但早期发现并不能完全消除这些差异。社区社会经济地位和婚姻状况的影响表明,社会决定因素、支持机制和获得医疗保健的机会是重要的促成因素。